Company / Current Assets
Lexaria Bioscience Corp. Current Assets History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$3.5M
FY2025
5-year range
$2.2M / $12.4M
FY2021-FY2025
Trend
-56.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has fluctuated over the past 10 years, ranging from $510,166 in FY2016 to $12M in FY2021.
Based on SEC 10-K filings.
$3M in FY2025 with a 10-year CAGR of +17.8%.
Improved from $2M to $3M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -20.8%
- 5-Year CAGR
- +12.5%
- 10-Year CAGR
- +17.8%
Key checks
Key Insights
- 5-year CAGR of +12.5%, indicating consistent growth.
- In FY2025, current assets decreased 56.1% year-over-year.
- Peak current assets was recorded in FY2021.
- Lowest current assets in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.5M | -56.1% |
| FY2024 | $7.9M | +259.0% |
| FY2023 | $2.2M | -68.5% |
| FY2022 | $7.0M | -43.9% |
| FY2021 | $12.4M | +546.1% |
| FY2020 | $1.9M | +5.9% |
| FY2019 | $1.8M | -34.9% |
| FY2017 | $2.8M | +448.0% |
| FY2016 | $510.2K | -24.4% |
| FY2015 | $674.7K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026